Pain Management Devices And Therapies Market Report 2026

Pain Management Devices And Therapies Market Overview

• Pain Management Devices And Therapies market size has reached to $5.34 billion in 2025 • Expected to grow to $7.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Prevalence Of Chronic Pain Conditions Fueling The Growth Of The Market Due To Increasing Demand For Long-Term, Non-Invasive Pain Management Solutions • Market Trend: Innovative Implantable Device Enhances Chronic Pain Management • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Pain Management Devices And Therapies Market?

Pain management devices and therapies manage chronic and critical pain in patients suffering from various conditions, such as cancer and neurological disorders. These are mainly used for spinal cord stimulation, sacral nerve stimulators, and deep brain stimulation. The main types of pain management devices and therapies market are electrical stimulators, ablation devices, neurostimulators, and analgesic pumps. The various electrical stimulation devices include transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, combination devices, electrotherapy devices, and TNS, ablation devices include radiofrequency ablation devices, cryoablation devices and neurostimulation devices including spinal cord stimulation (SCS) devices, deep brain stimulation devices, vagus nerve stimulation devices, and sacral nerve stimulation devices. The analgesic infusion pumps covered in this market are intrathecal, and external infusion pumps that are used for neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and trauma applications.

What Is The Pain Management Devices And Therapies Market Growth Forecast?

The pain management devices and therapies market size is expected to see strong growth in the next few years. It will grow to $7.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population growth, technological advances in neurostimulators, demand for long-term pain relief, expansion of outpatient pain clinics, increasing healthcare expenditure. Major trends in the forecast period include growing adoption of neurostimulation therapies, rising use of non-opioid pain management, expansion of implantable pain devices, increasing demand for chronic pain treatments, shift toward minimally invasive pain procedures.

Global Pain Management Devices And Therapies Market Segmentation

1) By Product Type: Electrical Stimulation Devices, Thermal Therapy Devices, Minimally Invasive Devices, Injection And Infusion Systems, Ultrasound And Laser Therapy Devices, Other Product Types 2) By Therapy Type: Pharmacologic Therapies, Non-Pharmacologic Therapies, Interventional Or Surgical Therapies 3) By Pain Indication: Chronic Pain, Acute Pain, Other Pain Conditions 4) By End User: Hospitals, Ambulatory Surgical Centers, Pain Clinics, Rehabilitation Centers, Home Healthcare, Specialty Clinics Or Outpatient Facilities Subsegments: 1) By Electrical Stimulation Devices: Spinal Cord Stimulators (Scs), Transcutaneous Electrical Nerve Stimulation (Tens), Interferential Current Therapy Devices, Peripheral Nerve Stimulators (Pns), Deep Brain Stimulation (Dbs) 2) By Thermal Therapy Devices: Cryotherapy Units, Heat Therapy Pads And Wraps 3) By Minimally Invasive Devices: Radiofrequency Ablation Devices, Epidural Catheters, Intrathecal Drug Delivery Systems, Neuroablative Devices 4) By Injection And Infusion Systems: Pain Infusion Pumps, Needle-Based Injectors 5) By Ultrasound And Laser Therapy Devices: Therapeutic Ultrasound, Low-Level Laser Therapy (Lllt) 6) By Other Product Types: Acupuncture Stimulators, Biofeedback And Rehabilitation Devices

What Is The Driver Of The Pain Management Devices And Therapies Market?

The rising prevalence of chronic pain conditions is expected to propel the growth of the pain management devices and therapies market going forward. Chronic pain conditions refer to persistent or recurrent pain lasting three months or longer that interferes with daily activities and overall quality of life. The rising prevalence of chronic pain is due to an aging population, as older adults are more susceptible to degenerative joint diseases and other chronic ailments that cause persistent discomfort. Pain management devices and therapies aid in chronic pain conditions by offering non-invasive and targeted relief, making them suitable for long-term management of various pain disorders. They improve patient comfort by delivering consistent, personalized pain control, enhancing overall quality of life. For instance, in November 2024, according to the National Center for Health Statistics, a US-based federal agency, approximately 24.3% of U.S. adults experienced chronic pain in 2023. Therefore, the rising prevalence of chronic pain conditions is driving the growth of the pain management devices and therapies industry.

Key Players In The Global Pain Management Devices And Therapies Market

Major companies operating in the pain management devices and therapies market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Baxter International Inc., Johnson & Johnson, Smiths Medical Inc., Becton Dickinson and Company, DJO Global Inc., B Braun Melsungen AG, Neurotech Na, Nevro Corp, NeuroMetrix Inc, Medovex Corporation, Halyard Health Inc, Flowonix Medical Inc, Pain Management Technologies Inc, Avanos Medical Inc, Stimwave Technologies LLC, Omron Healthcare Inc., Stryker Corporation, ICU Medical Inc., Nipro Corporation, Zynex Medical Inc., Saluda Medical Pty Ltd., SPR Therapeutics

Global Pain Management Devices And Therapies Market Trends and Insights

Major companies operating in the pain management devices and therapies market are focusing on developing advanced neuromodulation technologies, such as closed-loop spinal cord stimulation systems, to provide personalized pain relief, improve patient outcomes, and enhance therapy efficacy. Closed-loop spinal cord stimulation refers to an advanced therapeutic system that delivers electrical pulses to the spinal cord while simultaneously recording the spinal cord's neural response, automatically adjusting therapy in real-time to maintain consistent relief. For instance, in April 2024, Medtronic plc, a US-based healthcare technology company, received Food and Drug Administration (FDA) approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. It is a fully implantable device that features a proprietary sensing technology which captures the body's biological signals to deliver personalized, data-driven therapy. It includes automatic adjustment functionality, enabling real-time optimization of spinal cord stimulation to maintain a consistent dose of therapy for chronic pain without patient intervention.

What Are Latest Mergers And Acquisitions In The Pain Management Devices And Therapies Market?

In April 2025, Globus Medical Inc., a US-based musculoskeletal technology company, acquired Nevro Corp. for an undisclosed amount. Through this acquisition, Globus Medical aims to accelerate market penetration of Nevro’s differentiated high-frequency technology and expand treatment options for patients with chronic pain. Nevro Corp. is a US-based medical device company specializing in high-frequency spinal cord stimulation systems for chronic pain management.

Regional Outlook

North America was the largest region in the pain management devices and therapies market in 2025. Western Europe was the second-largest region in the pain management devices and therapies market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pain Management Devices And Therapies Market?

The pain management devices and therapies market consist of sales of physical therapy, massage, acupuncture, osteopathic manipulative treatment (OMT) and chiropractic adjustments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.